Newshot

Central South University reports 12 markings on a 1 cm ruler, flags AI paper controversy at affiliated hospitals and confirms academic misconduct

AI summary

IT之家 reported on November 19 that Central South University issued a notice on November 19 regarding online questions about the data and figures in three papers from the Second Xiangya Hospital and Xiangya Hospital. According to the notice, investigations found that the three papers contained fabricated or falsified experimental data and figures, with two also involving improper authorship, and the university announced penalties including demotions and bans on promotions, talent program applications, graduate admissions, awards, and government-funded scientific activities.

Translation(model translation, not the source's own text)

A 1-centimeter scale bar with 12 tick marks: Central South University reports on AI paper controversy at affiliated hospitals, confirms academic misconduct

IT之家, November 19 — Central South University issued a situation report on November 19: recently, questions appeared online about the data and figures in three papers from the Second Xiangya Hospital and Xiangya Hospital. The university attached great importance to the matter and immediately organized peer experts to verify materials such as experimental records, raw data, and submission records, and to interview relevant personnel. Based on the peer experts' verification results and after deliberation by the university's Academic Style Construction Committee, the relevant situation is reported as follows.

  • Questioned paper 1: "Ferroptosis inhibition via the ROS-GPX4 axis drives microplastic-induced malignant progression of nasopharyngeal carcinoma," published in 2025 in the journal Journal of Translational Medicine, first author 邓某某, corresponding author 赵某. Investigation found that the paper contains academic misconduct in the form of fabricated and falsified experimental research data and figures, improper authorship, and violations of research ethics norms.
  • Questioned paper 2: "Tumor-infiltrating B cells inhibit nasopharyngeal carcinoma metastasis," published in 2026 in the journal Cell Death & Disease, first author 蔡某, co-first author 谭某某, corresponding author 赵某. Investigation found that the paper contains academic misconduct in the form of fabricated and falsified experimental research data and figures and improper authorship.
  • Questioned paper 3: "Arvanil reverses cisplatin resistance in ovarian cancer by activating HMOX1-driven ferroptosis," published in 2026 in the journal Scientific Reports, with the first author and co-first author being individuals from outside the university, and the corresponding author being 邓某某. Investigation found that the paper contains academic misconduct in the form of fabricated and falsified experimental research data and figures.

In accordance with relevant provisions such as the Rules for Investigation and Handling of Research Integrity Violations and the Provisions on Disciplinary Action for Staff of Public Institutions, the following actions were taken against the relevant personnel:

  • For 邓某某 and 赵某, penalties of demotion in professional and technical post grade; within 5 years, their eligibility for promotion of position and professional title, application for talent programs, graduate student enrollment, awards and honors, etc., is revoked; within 10 years, they may not undertake science and technology activities supported by fiscal funds.
  • For 蔡某 and 谭某某, within 5 years, their eligibility for promotion of position and professional title, application for talent programs, graduate student enrollment, awards and honors, etc., is revoked; within 5 years, they may not undertake science and technology activities supported by fiscal funds.
  • Other relevant authors were given academic admonition talks.

Central South University stated that the university has always adhered to "zero tolerance" for academic misconduct, will further strengthen the construction of research conduct, improve the supervision and verification system, and resolutely safeguard a clean and upright academic ecosystem.

According to previous IT之家 reports, a nasopharyngeal carcinoma research paper published in Journal of Translational Medicine recently drew questions from netizens, and the related topic once trended on Weibo.

The paper's experimental images, data, and author affiliation information contained multiple irregularities, for example, a 1-centimeter scale bar that actually had 12 tick intervals. As a result, some netizens suspected that the relevant images might have been generated by AI.

On November 17, the Supervision and Integrity Division of the Hunan Provincial Department of Science and Technology responded that it had instructed the authors' institution, the Second Xiangya Hospital of Central South University, to launch an investigation, and that the department would also simultaneously verify whether there were issues of academic misconduct and research procedures.

Related articles

  • Research team investigation finds over 70% of English biomedical papers already use AI-assisted writing, calls on the industry to establish sound regulatory mechanisms
  • 62%→ 94%, "AI rate" rising instead of falling? CCTV explains the principles of AI detection for graduation theses
  • First case in the country: invasive brain-computer interface restores sight to a patient blind for 20 years
  • Sequoia China's Shen Nanpeng donates 300 million yuan to his alma mater Shanghai Jiao Tong University to establish the "Sequoia Academy Construction Fund"
  • Research shows a surge in fake references in medical papers, with AI partly to blame
  • WeChat AI team's Pattern Recognition Center paper wins top international signal processing award, the first time the award has gone to a Chinese company team since its establishment

The translation is machine-generated and individual terms may be off. Nothing is rewritten or cut; the original is authoritative.

Published by IT之家
This site only summarises and aggregates; copyright stays with the original author. Headlines and summaries follow the source — where they differ, the original wins.
Read the original ↗